Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy do notice increased sweating, particularly in the first weeks of treatment or after a dose increase. It is not listed as a common side effect in the licensed product information, but it does come up — and there are a few physiological reasons why it might happen. As a prescription-only medicine, Wegovy is only available following a clinical assessment; a prescriber reviews whether it is right for you before anything is dispensed. Here is what the evidence actually shows.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a jarring thing to notice. You started Wegovy a few weeks ago, things feel broadly fine, and then you wake up clammy at 3am or find yourself sweating more than usual at work. The instinct is to wonder whether the medicine is doing something unexpected.
The short answer is that sweating is not a recognised common side effect of semaglutide in the way that nausea or constipation is. The NHS semaglutide medicines page lists the typical GI-led effects (nausea, vomiting, diarrhoea, indigestion) but sweating does not appear prominently in that catalogue. That does not mean your experience is wrong. It means the mechanism is usually indirect.
The most likely culprit early in treatment is nausea itself. When you feel sick, your autonomic nervous system reacts: heart rate climbs slightly, blood vessels near the skin dilate, and you sweat. It is the same response you get with any strong wave of nausea, regardless of cause. If the sweating tends to arrive at the same time as a queasy spell, this is almost certainly what is happening. Most people find both symptoms ease considerably within two to four weeks as the body settles into the dose, and our overview of how Wegovy changes appetite and food intake explains more about that adjustment window.
A second, less common trigger is a blood-sugar dip. Semaglutide slows gastric emptying and reduces appetite in ways that can lead people to eat far less than they realise. If your blood glucose falls lower than usual (not into clinical hypoglycaemia necessarily, but lower than your norm) sweating, shakiness and light-headedness can follow. This is more relevant for people who also take other diabetes medications, but it can happen in anyone eating significantly less than before.
Night sweats are worth treating as a separate question because they have a long differential diagnosis that has nothing to do with weight-loss medicine. Perimenopause, thyroid changes, anxiety and infections all sit on that list. If you were having night sweats before you started Wegovy, the medicine is probably not the cause. If they started within a week or two of beginning or increasing your dose, our full guide to whether Wegovy makes you sweat more covers the timing patterns and what they might mean.
One mechanism worth knowing about: semaglutide reduces appetite substantially, and some people inadvertently eat too little during the day. Eating enough protein and staying properly hydrated on Wegovy matters more than people expect, undereating can destabilise blood sugar overnight and produce night sweating as a result. The fix is often simpler than it sounds: structured smaller meals with adequate protein, rather than skipping eating because you just are not hungry.
The question of how Wegovy changes hunger signals is something our dedicated page on hunger and appetite suppression covers in more detail. If you are curious whether Wegovy can sometimes cause hunger rather than suppress it, that is also worth reading before you assume every appetite change is straightforward. If you are finding your appetite so suppressed that you are barely eating anything, that is worth discussing with your prescriber rather than treating as a sign the medicine is working especially well.
Most of the time, increased sweating on Wegovy is benign and short-lived. But certain patterns deserve prompt attention.
If the sweating comes with severe or persistent stomach pain that spreads toward the back, stop and get medical help the same day, this combination can be a sign of acute pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update on GLP-1 medicines. Pancreatitis is uncommon but serious, and it should never be waited out at home.
Similarly, sweating alongside a racing heart, trembling, confusion or sudden faintness suggests a significant drop in blood sugar. This is worth an urgent call to your prescriber or GP. Do a quick self-check: think back over the last several hours, did you eat at all? Did you drink enough water? Sometimes the answer turns out to be straightforward, and that one-minute check helps you describe the context accurately when you do call.
You can report any suspected side effect from a licensed medicine (or flag a supplier you are uncertain about) through the MHRA Yellow Card scheme. It exists precisely so that real-world patterns get captured alongside trial data.
If you are considering starting Wegovy and want to understand how a GPhC-registered prescriber at nume would assess whether it is right for you, start your free consultation and a real clinician will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.